| Year |
Citation |
Score |
| 2022 |
Pathmanathan S, Yao Z, Coelho P, Valla R, Drecun L, Benz C, Snider J, Saraon P, Grozavu I, Kotlyar M, Jurisica I, Park M, Stagljar I. B cell linker protein (BLNK) is a regulator of Met receptor signaling and trafficking in non-small cell lung cancer. Iscience. 25: 105419. PMID 36388990 DOI: 10.1016/j.isci.2022.105419 |
0.341 |
|
| 2019 |
Drabovich AP, Saraon P, Drabovich M, Karakosta T, Dimitromanolakis A, Hyndman ME, Jarvi K, Diamandis EP. Multi-omics biomarker pipeline reveals elevated levels of protein-glutamine gamma-glutamyltransferase 4 in seminal plasma of prostate cancer patients. Molecular & Cellular Proteomics : McP. PMID 31249104 DOI: 10.1074/Mcp.Ra119.001612 |
0.629 |
|
| 2018 |
Saraon P, Grozavu I, Stagljar I. Testing cancer inhibitors at scale. Nature Biomedical Engineering. 2: 203-204. PMID 30936440 DOI: 10.1038/S41551-018-0226-X |
0.441 |
|
| 2017 |
Saraon P, Grozavu I, Lim SH, Snider J, Yao Z, Stagljar I. Detecting Membrane Protein-protein Interactions Using the Mammalian Membrane Two-hybrid (MaMTH) Assay. Current Protocols in Chemical Biology. 9: 38-54. PMID 28253435 DOI: 10.1002/Cpch.15 |
0.303 |
|
| 2015 |
Musrap N, Tuccitto A, Karagiannis GS, Saraon P, Batruch I, Diamandis EP. Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1). The Journal of Biological Chemistry. 290: 17218-27. PMID 26004777 DOI: 10.1074/Jbc.M115.639773 |
0.715 |
|
| 2015 |
Cretu D, Liang K, Saraon P, Batruch I, Diamandis EP, Chandran V. Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers. Clinical Proteomics. 12: 1. PMID 25678896 DOI: 10.1186/1559-0275-12-1 |
0.481 |
|
| 2015 |
Karagiannis GS, Musrap N, Saraon P, Treacy A, Schaeffer DF, Kirsch R, Riddell RH, Diamandis EP. Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression. Biological Chemistry. 396: 163-83. PMID 25153376 DOI: 10.1515/Hsz-2014-0221 |
0.699 |
|
| 2015 |
Musrap N, Tuccitto A, Karagiannis G, Saraon P, Diamandis E. Comparative proteomics of ovarian cancer spheroid formation reveals an increased expression of calcium-activated chloride channel regulator 1 Gynecologic Oncology. 137: 116. DOI: 10.1016/J.Ygyno.2015.01.288 |
0.651 |
|
| 2014 |
Saraon P, Drabovich AP, Jarvi KA, Diamandis EP. Mechanisms of Androgen-Independent Prostate Cancer. Ejifcc. 25: 42-54. PMID 27683456 |
0.6 |
|
| 2014 |
Cretu D, Prassas I, Saraon P, Batruch I, Gandhi R, Diamandis EP, Chandran V. Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry. Clinical Proteomics. 11: 27. PMID 25097465 DOI: 10.1186/1559-0275-11-27 |
0.674 |
|
| 2014 |
Musrap N, Karagiannis GS, Saraon P, Batruch I, Smith C, Diamandis EP. Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction. Journal of Proteomics. 103: 204-15. PMID 24726482 DOI: 10.1016/J.Jprot.2014.03.042 |
0.726 |
|
| 2014 |
Drabovich AP, Saraon P, Jarvi K, Diamandis EP. Seminal plasma as a diagnostic fluid for male reproductive system disorders. Nature Reviews. Urology. 11: 278-88. PMID 24709963 DOI: 10.1038/Nrurol.2014.74 |
0.49 |
|
| 2014 |
Karagiannis GS, Pavlou MP, Saraon P, Musrap N, Xie A, Batruch I, Prassas I, Dimitromanolakis A, Petraki C, Diamandis EP. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers. Journal of Proteomics. 103: 121-36. PMID 24681409 DOI: 10.1016/J.Jprot.2014.03.018 |
0.761 |
|
| 2014 |
Saraon P, Trudel D, Kron K, Dmitromanolakis A, Trachtenberg J, Bapat B, van der Kwast T, Jarvi KA, Diamandis EP. Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression. The Prostate. 74: 372-80. PMID 24311408 DOI: 10.1002/Pros.22758 |
0.66 |
|
| 2014 |
Karagiannis GS, Schaeffer DF, Cho CK, Musrap N, Saraon P, Batruch I, Grin A, Mitrovic B, Kirsch R, Riddell RH, Diamandis EP. Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin. Molecular Oncology. 8: 178-95. PMID 24268521 DOI: 10.1016/J.Molonc.2013.10.008 |
0.705 |
|
| 2014 |
Karagiannis GS, Saraon P, Jarvi KA, Diamandis EP. Proteomic signatures of angiogenesis in androgen-independent prostate cancer. The Prostate. 74: 260-72. PMID 24166580 DOI: 10.1002/Pros.22747 |
0.707 |
|
| 2013 |
Drabovich AP, Dimitromanolakis A, Saraon P, Soosaipillai A, Batruch I, Mullen B, Jarvi K, Diamandis EP. Differential diagnosis of azoospermia with proteomic biomarkers ECM1 and TEX101 quantified in seminal plasma. Science Translational Medicine. 5: 212ra160. PMID 24259048 DOI: 10.1126/Scitranslmed.3006260 |
0.486 |
|
| 2013 |
Saraon P, Cretu D, Musrap N, Karagiannis GS, Batruch I, Drabovich AP, van der Kwast T, Mizokami A, Morrissey C, Jarvi K, Diamandis EP. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression. Molecular & Cellular Proteomics : McP. 12: 1589-601. PMID 23443136 DOI: 10.1074/Mcp.M112.023887 |
0.754 |
|
| 2013 |
Bayani J, Kuzmanov U, Saraon P, Fung WA, Soosaipillai A, Squire JA, Diamandis EP. Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression. Clinical Chemistry. 59: 296-305. PMID 23136250 DOI: 10.1373/Clinchem.2012.193060 |
0.648 |
|
| 2012 |
Saraon P, Musrap N, Cretu D, Karagiannis GS, Batruch I, Smith C, Drabovich AP, Trudel D, van der Kwast T, Morrissey C, Jarvi KA, Diamandis EP. Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer. The Journal of Biological Chemistry. 287: 34019-31. PMID 22908226 DOI: 10.1074/Jbc.M112.384438 |
0.727 |
|
| 2012 |
Karagiannis GS, Petraki C, Prassas I, Saraon P, Musrap N, Dimitromanolakis A, Diamandis EP. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget. 3: 267-85. PMID 22408128 DOI: 10.18632/Oncotarget.451 |
0.771 |
|
| 2012 |
Saraon P, Jarvi K, Diamandis EP. Abstract C47: Quantitative mass spectrometry reveals that enzymes of the ketogenic pathway are upregulated during high-grade prostate cancer Cancer Research. 72: C47-C47. DOI: 10.1158/1538-7445.Prca2012-C47 |
0.701 |
|
| 2012 |
Saraon P, Jarvi K, Diamandis EP. Abstract LB-293: High-throughput proteomic analysis identifies protein s as a modulator of high grade and castrate-resistant prostate cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-293 |
0.68 |
|
| 2012 |
Saraon P, Cretu D, Jarvi K, Diamandis EP. Abstract 4119: High-throughput proteomics reveals that enzymes of the ketogenic pathway are upregulated during prostate cancer progression Cancer Research. 72: 4119-4119. DOI: 10.1158/1538-7445.Am2012-4119 |
0.707 |
|
| 2011 |
Saraon P, Jarvi K, Diamandis EP. Molecular alterations during progression of prostate cancer to androgen independence. Clinical Chemistry. 57: 1366-75. PMID 21956922 DOI: 10.1373/Clinchem.2011.165977 |
0.619 |
|
| 2011 |
Saraon P, Jarvi K, Diamandis EP. Abstract LB-332: High-throughput proteomic analysis identifies protein S as a potential modulator of androgen-independent prostate cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-332 |
0.68 |
|
| 2011 |
Saraon P, Batruch I, Smith C, Mizokami A, Jarvi K, Diamandis EP. Abstract 4870: High-throughput proteomics using stable isotope labelling with amino acids in cell culture (SILAC) reveals potential modulators of androgen-independent prostate cancers Cancer Research. 71: 4870-4870. DOI: 10.1158/1538-7445.Am2011-4870 |
0.686 |
|
| 2010 |
Duffy SP, Shing J, Saraon P, Berger LC, Eiden MV, Wilde A, Tailor CS. The Fowler syndrome-associated protein FLVCR2 is an importer of heme. Molecular and Cellular Biology. 30: 5318-24. PMID 20823265 DOI: 10.1128/Mcb.00690-10 |
0.34 |
|
| Show low-probability matches. |